PND is a poorly understood, catastrophic complication with high mortality and disability rates [24]. However, the mechanisms underlying PND remain largely uncertain. In this study, we focused on neuroinflammation-induced cognitive impairment and demonstrated that brain Tregs alleviate cognitive dysfunction by inhibiting central nervous system inflammatory responses. The potential clinical significance of our findings is that brain Tregs may provide a scientific basis for therapeutic strategies for PND.
The pathogenesis of PND involves multiple mechanisms, such as neuroinflammation, oxidative stress, and neurodegenerative changes [25–28]. Tregs play a pivotal role in the intricate process of effector T cell suppression, thereby maintaining self-tolerance and ensuring immune system homeostasis [29]. Moreover, the impairment of Tregs under neurodegenerative conditions leads to a loss of inflammation, ultimately resulting in the persistence of inflammatory environments within the central nervous system. This study investigated the impact of brain Tregs on neuroinflammation and inflammation-related PND in a mouse model of LPS-induced memory impairment.
The gut-brain axis refers to the interaction and communication between the gastrointestinal tract and the brain and encompasses the nervous, endocrine, and immune systems. Central inflammation and disruption of the gut microbiota can influence each other through the gut-brain axis. On the one hand, central inflammation can trigger excessive activation of the immune system, leading to increased release of inflammatory factors. These inflammatory factors may directly or indirectly impact the balance of the gut microbiota, suppressing the growth of beneficial bacteria and promoting the proliferation of harmful bacteria, thereby causing dysbiosis of the gut microbiota. On the other hand, dysbiosis of the gut microbiota may weaken intestinal barrier function, allowing harmful microorganisms and toxins to enter the bloodstream through the intestinal mucosa, triggering peripheral inflammatory responses. These inflammatory factors and metabolites can be transmitted to the brain through the gut-brain axis, leading to neuroinflammation and inflammation-related changes in neural transmission. 5-HT is synthesized primarily in enteric neurons and enterochromaffin cells located in the gastrointestinal muscularis. This intricate process involves the conversion of tryptophan, an amino acid obtained through the diet, into serotonin [30]. On the basis of previous studies on tryptophan-rich diet strategies to increase peripheral blood 5-HT levels in mice, our results showed that the tryptophan-rich diet can significantly reverse the decrease in peripheral blood serum 5-HT concentration and cognitive dysfunction caused by intracerebroventricular injection of LPS. This provides a method for activating brain Tregs in vivo. Recent studies have revealed the involvement of certain gut microbiota, such as members of the Klebsiella, Escherichia, Streptococcus, and Enterococcus genera, in the synthesis of 5-HT [15, 31]. Previous studies on the gut microbiota composition in mice with cognitive impairment have primarily utilized 16S rRNA analysis, limited to the identification of microorganisms at the genus or family level. In our investigation, we employed metagenomic sequencing to comprehensively investigate the gut microbiota at the species level. Our findings revealed a relative increase in the abundance of specific bacterial species, such as s_Escherichia coli, s_Klebsiella_pneumoniae, s_Klebsiella_quasipneumoniae, and s_Klebsiella_variicola, in mice following microinjection of LPS. This provides a direction for future research on the impact of specific bacterial species on PND.
Tregs, by their ability to abrogate the pathogenic activities of immune cells and sustain immunological tolerance toward self-antigens, have garnered considerable attention over the years. Tregs exert immune suppressive effects through three main pathways: 1) inhibiting cytokine production or promoting effector T cell proliferation; 2) engaging in the direct secretion of cytokines, notably TGF-β and IL-10, thus orchestrating the cytokine milieu at the inflammatory site; and 3) directly killing cytotoxic cells [32]. Based on the systematic study of Tregs by Minako et al. [13], we proposed that the reduced activation of brain Tregs is due to a decrease in peripheral blood 5-HT levels. Consequently, when we increased the peripheral blood 5-HT concentration by providing the diet rich in tryptophan, we observed a significant improvement in cognitive function in mice following intracerebroventricular microinjection of LPS. Building upon the comprehensive investigation of Tregs by Minako et al. [13], we posited that the diminished activation of brain Tregs stems from reduced peripheral blood 5-HT levels, while augmenting peripheral blood 5-HT can stimulate the proliferation and activation of brain Tregs. Thus, we observed that mice receiving the tryptophan-rich diet to increase peripheral blood 5-HT levels after intracerebroventricular injection of LPS exhibited significantly greater proportions of brain Tregs in the cervical lymph nodes and hippocampus than mice receiving only intracerebroventricular injection of LPS. Additionally, there was an elevation in central anti-inflammatory factor levels, a reduction in inflammatory cell and proinflammatory factor levels, and alleviation of demyelination in neurons. Moreover, the cognitive function of the mice improved.
Current evidence suggests the potential interplay between immune dysregulation and cognitive decline in individuals with mild cognitive impairment or mild AD. Studies have revealed elevated levels of activated CD4+ T and CD8+ T cells in these individuals, indicating an aberrant immune response [33]. Notably, increased activation of CD8+ T cells has been linked to compromised language acquisition, visual-spatial abilities, and hippocampal degradation, which are hallmark features of cognitive impairment [34]. This finding points toward a potential association between the cognitive manifestations of AD and the heightened activation of CD8+ T cells. Furthermore, investigations have shown elevated quantities of effector memory CD8+ T cells in the CSF of AD patients, highlighting their involvement in central inflammation [35]. Previous investigations conducted by our research group and other scholars have revealed notable infiltration of CD8+ T cells within the cerebral parenchyma of mice afflicted with ischemic stroke. These CD8+ T-cell-derived Prf and GranzB compounds have been determined to play a significant role in neurotoxicity, exacerbating perioperative ischemic brain injury and subsequently leading to cognitive impairment [11, 36]. These findings suggested that CD8+ T cells play a pivotal role in mediating inflammation and cognitive impairment. In coculture experiments, 5-HT was shown to enhance the immunosuppressive effect of primary Tregs on primary CD8+ T cells through activation of the Htr7 receptor. These findings indicated that 5-HT amplifies the immunosuppressive effects of Tregs on primary CD8+ T cells through the activation of the Htr7 receptor.
The activation of microglia plays a key role in promoting neuroinflammation, a process implicated in various neurological disorders [37]. Currently, an increasing number of studies are related to the M1/M2 paradigm of microglial activation, wherein the M1 phenotype of microglia represents a proinflammatory state, while the M2 phenotype embodies an anti-inflammatory state [38]. Notably, exposure of microglia to LPS and sevoflurane, a commonly used anesthetic, stimulates the expression of the proinflammatory cytokines IL-1β and IL-6 [39]. Similarly, the administration of isoflurane, another anesthetic, has been shown to promote microglial inflammation and induce cognitive decline in elderly mice [40]. In an effort to mitigate these detrimental effects, researchers have focused on upregulating the expression of IL-10 in microglia, which can inhibit the NF-κB/MAPK pathway and alleviate POCD [41]. Additionally, the activation of 5-HT receptors has emerged as a promising strategy for limiting neuroinflammation. By reducing astrocyte and microglial reactivity, 5-HT receptor activation protects the brain from inflammation-induced neurodegenerative changes [42, 43]. The aforementioned studies primarily concentrated on the activation of hippocampal 5-HT receptors. In the present study, we investigated the importance of Htr7 receptors positioned on the surface of peripheral Tregs. We cocultured primary Tregs with primary microglia and found that in the 5-HT group, microglia exhibited a decrease in M1 polarization, which enhanced the inflammatory response, and an increase in M2 polarization, which promoted neural repair. Furthermore, the 5-HT group exhibited significant decreases in the concentrations of IL-1β and TNF-α. However, when 5-HT and Htr7 receptor antagonists were added to the culture medium, this enhanced immunosuppressive effect was blocked. These findings suggested that 5-HT enhances the immunosuppressive effect of primary Tregs on primary microglia through the Htr7 receptor.
The addition of 5-HT to culture media enhances the immunosuppressive effects of primary Tregs on cocultured primary CD8+ T cells and primary microglia. However, the simultaneous addition of 5-HT and an Htr7 receptor antagonist to the culture medium abolished the suppressive effects of primary CD8+ T cells and primary microglia on cocultured primary Tregs. These findings further substantiated the crucial immunomodulatory role of brain Tregs.
Rag1−/− mice lack mature T and B cells. Following intravenous injection of primary Tregs, the impact of Tregs on neuroinflammation and cognitive function in Rag1−/− mice can be observed independently, thereby eliminating interference from other T and B lymphocytes. By selectively transferring brain Tregs into Rag1−/− mice in vivo, the attenuation of Htr7 expression on the surface of brain Tregs intensified the cognitive impairment and neuroinflammatory responses induced by the administration of LPS. These data support our conclusion that brain Tregs can alleviate the cognitive impairments caused by LPS-induced neuroinflammation.
There are several limitations in our study. First, the pathogenesis of PND is complex, and neuroinflammation is one of the major contributing factors. It would be beneficial to conduct further investigations using surgical models in aged mice. Second, dysbiosis of the gut microbiota may also contribute to neuroinflammation, and the involvement of Tregs in suppressing gut dysbiosis warrants further exploration. Third, proteomic analysis revealed numerous inflammation-related proteins, the synergistic effects of which on the onset and progression of neuroinflammation-induced PND remain elusive, as they are beyond the scope of this study.